TY  - GEN
AU  - Rascol,O
AU  - Arnulf,I
AU  - Peyro-Saint Paul,H
AU  - Brefel-Courbon,C
AU  - Vidailhet,M
AU  - Thalamas,C
AU  - Bonnet,A M
AU  - Descombes,S
AU  - Bejjani,B
AU  - Fabre,N
AU  - Montastruc,J L
AU  - Agid,Y
TI  - Idazoxan, an alpha-2 antagonist, and L-DOPA-induced dyskinesias in patients with Parkinson's disease
SN  - 0885-3185
PY  - 2001///1018
KW  - Administration, Oral
KW  - Adrenergic alpha-Antagonists
KW  - adverse effects
KW  - Aged
KW  - Antiparkinson Agents
KW  - Dose-Response Relationship, Drug
KW  - Dyskinesia, Drug-Induced
KW  - drug therapy
KW  - Female
KW  - Humans
KW  - Idazoxan
KW  - Levodopa
KW  - Male
KW  - Middle Aged
KW  - Neurologic Examination
KW  - drug effects
KW  - Parkinson Disease
KW  - Pilot Projects
N1  - Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1002/mds.1143
ER  -